# Eli Lilly and Company (LLY): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/lly for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NYSE · Trading currency: USD

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity....

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $1,273.46 USD |
| Market Cap | $1.20T |
| P/E (TTM) | 40.44 |
| EPS (TTM) | $31.49 |
| 52-Week Range | $809.63 – $1,321.21 |
| Dividend Yield (TTM) | 0.53% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 0.53% |
| Annual Dividend (TTM) | $6.69 /share |
| Annual Dividend (Forward) | $6.92 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 12 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 15.3% / 15.3% / 15.3% / 13.0% |
| Payout Ratio (EPS, TTM) | 21.7% |
| Payout Ratio (FCF, TTM) | 28.7% |
| Payout Ratio (EPS, forward dividend) | 23.2% |
| Payout Ratio (FCF, forward dividend) | 30.8% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-08-14 | $1.7300 | 2026-09-10 |
| 2026-05-15 | $1.7300 | 2026-06-10 |
| 2026-02-13 | $1.7300 | 2026-03-10 |
| 2025-11-14 | $1.5000 | 2025-12-10 |
| 2025-08-15 | $1.5000 | 2025-09-10 |
| 2025-05-16 | $1.5000 | 2025-06-10 |
| 2025-02-14 | $1.5000 | 2025-03-10 |
| 2024-11-15 | $1.3000 | 2024-12-10 |
| 2024-08-15 | $1.3000 | 2024-09-10 |
| 2024-05-15 | $1.3000 | 2024-06-10 |
| 2024-02-14 | $1.3000 | 2024-03-08 |
| 2023-11-14 | $1.1300 | 2023-12-08 |

Full history: https://www.dividenddata.com/stocks/lly/dividend

## Frequently Asked Questions

### What does Eli Lilly and Company do?

Eli Lilly and Company (LLY) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is LLY's market cap?

Eli Lilly and Company (LLY) has a market capitalization of approximately $1.20 trillion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does LLY pay a dividend?

Yes, Eli Lilly and Company (LLY) pays a dividend quarterly, with a trailing-twelve-month yield of 0.53%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does LLY pay dividends?

Eli Lilly and Company pays dividends quarterly. The forward annual rate is $6.92 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is LLY's payout ratio?

Eli Lilly and Company's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/lly
- Dividend history & safety: https://www.dividenddata.com/stocks/lly/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/lly/earnings
- Financial statements: https://www.dividenddata.com/stocks/lly/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/lly/valuation
- Peer comparison: https://www.dividenddata.com/stocks/lly/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.